Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Esophageal Cancer Tissue Banking (ESBX)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Washington University School of Medicine.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Washington University School of Medicine Identifier:
First received: January 29, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
To create an esophageal cancer biospecimen repository that will collect, annotate, store and distribute human esophageal cancer biospecimens in a manner that embraces the highest ethical standards of human subject's research, that conforms to the best practices of biorepository science and that furthers basic, translational and clinical research in the understanding diagnosis and treatment of this disease.

Esophageal Cancer

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Prospective Collection of Health Information and Biospecimens in Esophageal Cancer

Resource links provided by NLM:

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Prospective Database [ Time Frame: five years ] [ Designated as safety issue: No ]
    A prospective database which would be maintained in the Division of Cardiothoracic Surgery would be able to link clinical outcomes to processed tissues (pathologic specimens, research specimens and plasma) enabling higher level correlation studies to be performed. Proper use of such a resource will aid considerably in our ability to advance our field and care for our future patients with esophageal cancer.

Biospecimen Retention:   Samples With DNA
peripheral blood and Esophageal Tissue

Estimated Enrollment: 250
Study Start Date: January 2011
Estimated Study Completion Date: January 2016
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Subjects will be identified by participating staff in the clinics of the surgical oncology or medical oncology clinics, and patients referred to the endoscopy center, and provided information about the biorepository.

Inclusion Criteria:

  • Adults with known or suspected esophageal cancer who are willing and able to give written informed consent for biospecimen collections.
  • Age ≥ 18 years
  • Must be willing and able to sign an informed consent document

Exclusion Criteria:

  • Pediatric patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01780961

Contact: Jasmine A Lewis, BSBA 314-362-4611
Contact: Joanne F Musick, RN,BSN 314-747-0707

United States, Missouri
Washington University School of Medicine Recruiting
St. Louis, Missouri, United States, 63110
Contact: Jasmine A Lewis, BSBA    314-362-4611   
Contact: Joanne F Musick, BSN    314-747-0707   
Principal Investigator: Varun Puri, MD         
Sponsors and Collaborators
Washington University School of Medicine
  More Information

Responsible Party: Washington University School of Medicine Identifier: NCT01780961     History of Changes
Other Study ID Numbers: 201101765 
Study First Received: January 29, 2013
Last Updated: January 29, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
Esophageal Cancer

Additional relevant MeSH terms:
Esophageal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Head and Neck Neoplasms
Digestive System Diseases
Esophageal Diseases
Gastrointestinal Diseases processed this record on October 20, 2016